Dimensional Fund Advisors LP Zynerba Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.86 - $2.06 $113,851 - $272,713	-132,385 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.83 - $3.02 $124,004 - $204,641	67,762 Added 104.86%	132,385 $271,000
Q3 2021 Nov 12, 2021	BUY	$3.72 - $5.35 $42,076 - $60,513	11,311 Added 21.22%	64,623 $274,000
Q2 2021 Aug 12, 2021	SELL	$3.83 - $5.98 $5,951 - $9,292	-1,554 Reduced 2.83%	53,312 $282,000
Q4 2020 Feb 25, 2021	BUY	$3.27 - $4.64 $179,411 - $254,578	54,866 New	54,866 $181,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.